 |
The Journal of Neuroscience, July 5, 2006, 26(27):7151-7155; doi:10.1523/JNEUROSCI.1790-06.2006
Previous Article | Next Article 
Mini-Reviews
Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond
Aaron W. Grossman,1,2,3 *
Georgina M. Aldridge,1,2,3 *
Ivan Jeanne Weiler,1 and
William T. Greenough1,2,4
1Beckman Institute, 2Neuroscience Graduate Program, 3Medical Scholars Program, and 4Departments of Psychology, Psychiatry, and Cell and Structural Biology, University of Illinois at UrbanaChampaign, Urbana, Illinois 61801
Correspondence should be addressed to Dr. William T. Greenough, Beckman Institute, University of Illinois at UrbanaChampaign, 405 North Mathews, Urbana, IL 61801. Email: wgreenou{at}uiuc.edu
Behavioral experiences can modulate neural networks through changes in synaptic morphology and number. In contrast, abnormal morphogenesis of dendritic spines is associated with cognitive impairment, as in Fragile X syndrome. Dendritic or synaptic protein synthesis could provide the specificity and speed necessary for spine morphogenesis. Here, we highlight locally translated proteins shown to affect synaptic morphology (e.g., Fragile X mental retardation protein).
Key words: synaptic plasticity, CaMKII; FMRP; Rho GTPases; Fmr1 knock-out mice; synaptogenesis; learning and memory; metabotropic glutamate receptor; Rac1; SHANK-HOMER; dendritic spine; PSD-95
Received April 27, 2006;
revised May 27, 2006;
accepted May 28, 2006.
Correspondence should be addressed to Dr. William T. Greenough, Beckman Institute, University of Illinois at UrbanaChampaign, 405 North Mathews, Urbana, IL 61801. Email: wgreenou{at}uiuc.edu
This article has been cited by other articles:

|
 |

|
 |
 
H. Wang, H. Fukushima, S. Kida, and M. Zhuo
Ca2+/Calmodulin-dependent Protein Kinase IV Links Group I Metabotropic Glutamate Receptors to Fragile X Mental Retardation Protein in Cingulate Cortex
J. Biol. Chem.,
July 10, 2009;
284(28):
18953 - 18962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Berry-Kravis, D Hessl, S Coffey, C Hervey, A Schneider, J Yuhas, J Hutchison, M Snape, M Tranfaglia, D V Nguyen, et al.
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
J. Med. Genet.,
April 1, 2009;
46(4):
266 - 271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Hagerman, E. Berry-Kravis, W. E. Kaufmann, M. Y. Ono, N. Tartaglia, A. Lachiewicz, R. Kronk, C. Delahunty, D. Hessl, J. Visootsak, et al.
Advances in the Treatment of Fragile X Syndrome
Pediatrics,
January 1, 2009;
123(1):
378 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Ma, D. D. Kiraly, E. D. Gaier, Y. Wang, E.-J. Kim, E. S. Levine, B. A. Eipper, and R. E. Mains
Kalirin-7 Is Required for Synaptic Structure and Function
J. Neurosci.,
November 19, 2008;
28(47):
12368 - 12382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Gibson, A. F. Bartley, S. A. Hays, and K. M. Huber
Imbalance of Neocortical Excitation and Inhibition and Altered UP States Reflect Network Hyperexcitability in the Mouse Model of Fragile X Syndrome
J Neurophysiol,
November 1, 2008;
100(5):
2615 - 2626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liao, S. K. Park, T. Xu, P. Vanderklish, and J. R. Yates III
Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice
PNAS,
October 7, 2008;
105(40):
15281 - 15286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Maussion, J. Carayol, A.-M. Lepagnol-Bestel, F. Tores, Y. Loe-Mie, U. Milbreta, F. Rousseau, K. Fontaine, J. Renaud, J.-M. Moalic, et al.
Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism
Hum. Mol. Genet.,
August 15, 2008;
17(16):
2541 - 2551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, L.-J. Wu, F. Zhang, and M. Zhuo
Roles of Calcium-Stimulated Adenylyl Cyclase and Calmodulin-Dependent Protein Kinase IV in the Regulation of FMRP by Group I Metabotropic Glutamate Receptors
J. Neurosci.,
April 23, 2008;
28(17):
4385 - 4397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iacoangeli, T. S. Rozhdestvensky, N. Dolzhanskaya, B. Tournier, J. Schutt, J. Brosius, R. B. Denman, E. W. Khandjian, S. Kindler, and H. Tiedge
On BC1 RNA and the fragile X mental retardation protein
PNAS,
January 15, 2008;
105(2):
734 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Hayashi, B. S. S. Rao, J.-S. Seo, H.-S. Choi, B. M. Dolan, S.-Y. Choi, S. Chattarji, and S. Tonegawa
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
PNAS,
July 3, 2007;
104(27):
11489 - 11494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Pfeiffer and K. M. Huber
Fragile X Mental Retardation Protein Induces Synapse Loss through Acute Postsynaptic Translational Regulation
J. Neurosci.,
March 21, 2007;
27(12):
3120 - 3130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C. Martin and R. S. Zukin
RNA trafficking and local protein synthesis in dendrites: an overview.
J. Neurosci.,
July 5, 2006;
26(27):
7131 - 7134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Wells
RNA-binding proteins: a lesson in repression.
J. Neurosci.,
July 5, 2006;
26(27):
7135 - 7138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hirokawa
mRNA transport in dendrites: RNA granules, motors, and tracks.
J. Neurosci.,
July 5, 2006;
26(27):
7139 - 7142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Pfeiffer and K. M. Huber
Current advances in local protein synthesis and synaptic plasticity.
J. Neurosci.,
July 5, 2006;
26(27):
7147 - 7150.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|